Regular consumption of coffee and caffeine in moderate amounts may have a protective effect against the development of multiple cardiometabolic diseases, including type 2 diabetes, coronary heart disease, and stroke.
Obesity, diabetes, cardiovascular diseases, fatty liver disease… The increase in the number of people suffering from cardiometabolic diseases in the world is becoming a public health concern. Worse, with the aging of the population, many people suffer from several pathologies, what is called cardiometabolic multimorbidity.
“People with a single cardiometabolic disease may have twice the risk of all-cause mortality compared to those without it“, explain scientists from Soochow University (Taiwan).And those with cardiometabolic multimorbidity may have an almost 4- to 7-fold increased risk of all-cause mortality..”
The focus is therefore on prevention to prevent these diseases from developing. While many studies have revealed the protective effects of coffee, tea and caffeine consumption on the morbidity of single cardiometabolic diseases, the potential effects of these beverages on the development of multiple pathologies were largely unknown.
A set of benefits
To fill this gap, the Taiwanese researchers drew on the UK Biobank, a large study of diet and health data from more than 500,000 participants aged 37 to 73.
Result : “Coffee and caffeine consumption (decaf does not count, editor’s note) at all levels was inversely associated with the risk of developing cardiometabolic multimorbidity.” Precisely, “Consuming three cups of coffee, or 200 to 300 mg of caffeine per day, may help reduce this risk“.
What mechanisms?
While the authors do not specify the nature of the protective effects of coffee, a complete review of its benefits, conducted last July, revealed “a complex interplay of antioxidant, anti-inflammatory, lipid-modulating, insulin-sensitizing effects… These mechanisms collectively contribute to reducing the risk of a spectrum of adverse cardiometabolic outcomes, including hypertension, metabolic syndrome, type 2 diabetes, cardiovascular disease, and all-cause mortality.“.
